Literature DB >> 10831476

Anxiety as a correlate of response to the acute treatment of bipolar I disorder.

U Feske1, E Frank, A G Mallinger, P R Houck, A Fagiolini, M K Shear, V J Grochocinski, D J Kupfer.   

Abstract

OBJECTIVE: Given the adverse impact of anxiety on treatment outcome in unipolar depression and the paucity of data on the role of anxiety in bipolar disorder, the authors sought to determine the effect of anxiety on the acute treatment response of patients with bipolar I disorder.
METHOD: The authors examined the correlates of response to the acute treatment of 124 consecutively treated patients with bipolar I disorder. Measures of anxiety included history of panic attacks and a composite variable reflecting current or past anxiety symptoms.
RESULTS: History of panic attacks proved to be a significant correlate of nonremission. Anxiety, as assessed with the composite variable, was associated with longer time to remission, as was the treatment of depressive versus manic symptoms and mixed versus manic symptoms. Patients with anxiety as assessed with the composite variable and patients with a history of panic attacks reported more severe medication side effects. They also required a greater number of medications, either sequentially or in combination, in order to achieve remission.
CONCLUSIONS: The findings suggest that anxiety is a clinically meaningful correlate of poor outcome in the acute treatment of bipolar I disorder.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831476     DOI: 10.1176/appi.ajp.157.6.956

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  46 in total

Review 1.  BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity.

Authors:  J J Rakofsky; K J Ressler; B W Dunlop
Journal:  Mol Psychiatry       Date:  2011-09-20       Impact factor: 15.992

2.  Psychosocial predictors of mood symptoms 1 year after acute phase treatment of bipolar I disorder.

Authors:  Lauren M Weinstock; Ivan W Miller
Journal:  Compr Psychiatry       Date:  2010-03-12       Impact factor: 3.735

3.  Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics.

Authors:  Keming Gao; David E Kemp; Elizabeth Fein; Zuowei Wang; Yiru Fang; Stephen J Ganocy; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2010-10-19       Impact factor: 4.384

4.  Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population.

Authors:  Regina Sala; Benjamin I Goldstein; Carmen Morcillo; Shang-Min Liu; Mariela Castellanos; Carlos Blanco
Journal:  J Psychiatr Res       Date:  2012-04-24       Impact factor: 4.791

Review 5.  Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder.

Authors:  Zuowei Wang; David E Kemp; Philip K Chan; Yiru Fang; Stephen J Ganocy; Joseph R Calabrese; Keming Gao
Journal:  Int J Neuropsychopharmacol       Date:  2010-09-29       Impact factor: 5.176

Review 6.  Comorbidity in pediatric bipolar disorder.

Authors:  Gagan Joshi; Timothy Wilens
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2009-04

7.  Cued panic attacks in body dysmorphic disorder.

Authors:  Katharine A Phillips; William Menard; Andri S Bjornsson
Journal:  J Psychiatr Pract       Date:  2013-05       Impact factor: 1.325

8.  Anxiety in children with mood disorders: a treatment help or hindrance?

Authors:  Colleen M Cummings; Mary A Fristad
Journal:  J Abnorm Child Psychol       Date:  2012-04

Review 9.  The psychopathology and treatment of bipolar disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

10.  Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized, placebo-controlled studies.

Authors:  R Bruce Lydiard; Larry Culpepper; Helena Schiöler; Urban Gustafsson; Björn Paulsson
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.